Breast Cancer Screening: One Size Doesn't Fit All
 

Additional resources

Overview

Different age groups

Specific populations

High-risk women

Breast exams

Additional resources & References

Quiz

(Use the following link for a printable handout of the Additional resources.)

Clinical guidelines for breast cancer screening

U.S. Preventive Services Task Force: American Cancer Society: National Comprehensive Cancer Network (NCCN):

Cancer data resources

Centers for Disease Control and Prevention

National Cancer Institute - Surveillance Epidemiology and End Results program

NCI and CDC - State Cancer Profiles

Screening and treatment resources for low-income, un/underinsured women

CDC National Breast and Cervical Cancer Early Detection Program (NBCCEDP)

  • Breast and cervical cancer screenings for low-income, underinsured women
  • Web links for state and territorial programs and other national partner organizations
  • Fact sheets and program publications

Federal Medicaid Breast and Cervical Cancer Prevention and Treatment

  • Most women screened or diagnosed through a state NBCCEDP, and who are diagnosed and need treatment for breast or cervical cancer, are eligible to get treatment covered through their state Medicaid program

Wisconsin Well Woman Program (WWWP)

  • Breast and cervical cancer screenings for low-income, underinsured women

Wisconsin Well Woman Medicaid (WWWMA)

  • Treatment for breast or cervical cancer for most women screened or diagnosed through WWWP or Wisconsin's Medicaid Family Planning Waiver

Wisconsin Cancer Drug Repository

  • Cancer patients can donate unused or discontinued medications and supplies to a participating pharmacy or medical facility, so those items can be shared with cancer patients who are uninsured or underinsured.

American Cancer Society - Navigator

  • Toll-free number to access free, confidential assistance to cancer patients and their families (e.g., provide cancer information, assist in locating local and national resources and support services, arrange for assistive devices, wigs/hats, prostheses) 1-800-227-2345

Komen Foundation - Breast Care Helpline & Linking A.R.M.S.

  • Toll-free number for information on breast cancer and referrals to "Linking A.R.M.S.," a joint Komen and CancerCare program for economically disadvantaged breast cancer patients. Eligible breast cancer patients may receive financial assistance grants of up to $300 to help cover oral medication, lymphedema care, and medical equipment. 1-800-462-9273

CancerCare - Assist

  • Toll-free number to help cancer patients find financial assistance for cancer care or supports, and limited financial assistance for cancer-related costs (e.g., pain medication, transportation to/from treatment, home care, child care) for financially eligible cancer patients. 1-800-813-4673

Links to patient education resources

Breast cancer

Cancer & underserved populations


References

Agency for HealthCare Research and Quality, U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. Rockville, MD.

Agency for HealthCare Research and Quality, U.S. Preventive Services Task Force. (2002). Screening for breast cancer. Rockville, MD.

American Cancer Society. (2004). Wisconsin Cancer Facts & Figures: 2003-2004. Atlanta, GA.

American Cancer Society. (2003). Cancer facts and figures 2003. Atlanta, GA.

Berry, D., Cronin, K., Plevritis, S., Fryback, D., Clarke, L., Zelen, M., et al. (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine, 353, 1784-1792.

Breast Health Access for Women with Disabilities. (2001). Table manners and beyond. Berkeley, CA.

Centers for Disease Control and Prevention - National Breast and Cervical Cancer Early Detection Program.

Claus, E., Risch, N., & Thompson, W. (1994). Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction. Cancer, 73(3), 643-651.

Dibble, S., Roberts, S. & Nussey, B. (2004). Comparing breast cancer risk between lesbians and their heterosexual sisters. Women's Health Issues, 14, 60-68.

Eklund, G. W. (1988). Improving imaging of the augmented breast. American Journal of Radiology, 151, 469-73.

El-Bastawissi A. Y., et al. (2001). Variation in mammographic breast density by race. Annals of Epidemiology, 11, 257-63.

Elmore, J. G., et al. (1998). Ten-year risk of false positive screening mammograms and clinical breast examinations. New England Journal of Medicine, 338(16), 1089-1096.

Fletcher, S. (2004). Screening for breast cancer. UpToDate, Wellesley, MA.

Fletcher, S. W., et al. (1993). Report of the international workshop on screening for breast cancer. Journal of the National Cancer Institute, 85, 1644-56.

Gail, M., Brinton, L., Byar, D. et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute, 81(24), 1879-1886.

Imaginis. (2005). Breast cancer screening and prevention.

Jones, B. A. (2003). Mammography screening in African American women: Evaluating the research. Cancer, 97 (1 Suppl), 258-72.

Komenaka I. K. (2004). The development of interval breast malignancies in patients with BRCA mutations. Cancer, 100, 2079-83.

Levavi H. (2003). BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers. European Journal of Gynecological Oncology, 24(6), 463-6.

The Mautner Project - The National Lesbian Health Organization.

National Cancer Institute. (2005). Digital vs. film mammography in the digital mammographic imaging screening trial (DMIST): Questions and answers. Bethesda, MD.

National Cancer Institute. (2000). Breast cancer risk assessment tool. Bethesda, MD.

National Cancer Institute. (2005). Genetics of Breast and Ovarian Cancer: Models of prediction of breast cancer risk. Bethesda, MD.

Persson, I., Thurfjell E., Holmberg L. (1997). Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. Journal of Clinical Oncology, 15(10), 3201-3207.

Pinckney, R., Geller, B., Burman, M., & Littenberg, B. (2003). Effect of false-positive mammograms on return for subsequent screening mammography. American Journal of Medicine, 114(2), 120-125.

Ries, L., Eisner, M. Kosary, C. Hankey, B., Miller, B., Clegg, L., et al. (Eds.). (2004). SEER cancer statistics review, 1975-2001. National Cancer Institute. Bethesda, MD.

Saslow, D., et. al. (2004). Clinical breast examination: Practical recommendations for optimizing performance and reporting. CA: A Cancer Journal for Clinicians, 54(6), 327-344.

Smalley, S. M. (2003). Breast implants and breast cancer screening. Journal of Midwifery and Women's Health, 48(5), 329-37.


  Back   Next
 

Copyright © 2005